Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

43 insider filings · Latest: Sep 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 6, 2026Apr 6 8:55 PMQuart Barry D
Proposed Sale
20,000$50.00$1.0M—

View →

Apr 6, 2026Apr 6 8:54 PMPatel Sanj K
Proposed Sale
219,591$50.00$11.0M—

View →

Apr 6, 2026Apr 6 8:04 PMMoat Ross
Proposed Sale
2,367$48.58$115.0K—

View →

Mar 9, 2026Mar 11 8:38 PMMark RagosaCHIEF FINANCIAL OFFICER
Sale
36,722$45.92$1.7M12,086(D)

View →

Mar 9, 2026Mar 9 9:24 PMRagosa Mark
Proposed Sale
36,722$45.92$1.7M—

View →

Mar 2, 2026Mar 4 9:40 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Sale
40,000$44.82$1.8M61,324(D)

View →

Mar 2, 2026Mar 2 10:22 PMPaolini John F.
Proposed Sale
40,000$44.82$1.8M—

View →

Feb 12, 2026Feb 12 9:34 PMBarry D QuartDirector
Sale
2,690$45.00$121.0K12,546(D)

View →

Feb 10, 2026Feb 12 9:34 PMBarry D QuartDirector
Sale
110$45.00$5.0K12,546(D)

View →

Feb 9, 2026Feb 11 9:38 PMMark RagosaCHIEF FINANCIAL OFFICER
Sale
17,845$43.28$772.3K12,086(D)

View →

Feb 4, 2026Feb 4 11:24 PMBarry D QuartDirector
Sale
2,602$45.02$117.1K12,546(D)

View →

Feb 3, 2026Feb 4 11:24 PMBarry D QuartDirector
Sale
12,528$45.27$567.1K12,546(D)

View →

Feb 2, 2026Feb 4 11:24 PMBarry D QuartDirector
Sale
830$45.00$37.4K12,546(D)

View →

Dec 15, 2025Dec 15 10:13 PMQuart Barry D
Proposed Sale
58,889$41.51$2.4M—

View →

Dec 8, 2025Dec 8 10:06 PMRagosa Mark
Proposed Sale
72,686$41.49$3.0M—

View →

Nov 26, 2025Nov 26 10:24 PMTessari Eben
Proposed Sale
48,384$42.89$2.1M—

View →

Nov 17, 2025Nov 17 10:07 PMTessari Eben
Proposed Sale
12,470$41.24$514.2K—

View →

Oct 31, 2025Oct 31 9:15 PMPaolini John F.
Proposed Sale
82,542$37.14$3.1M—

View →

Oct 28, 2025Oct 28 8:54 PMRagosa Mark
Proposed Sale
20,000$41.00$820.0K—

View →

Oct 28, 2025Oct 28 8:52 PMRagosa Mark
Proposed Sale
20,000$41.00$820.0K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:30 PMBAKER BROS. ADVISORS LPDirector
Grant/Award
72,948$48.3836,474(I)

View →

May 1, 2026May 5 8:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
58,424$10.3629,670(D)

View →

May 1, 2026May 1 8:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
48,565$30.930(D)

View →

Apr 30, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
2,141$30.9348,565(D)

View →

Apr 29, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
22,544$30.9350,706(D)

View →

Apr 28, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
483,654$30.9373,250(D)

View →

Apr 28, 2026Apr 29 8:46 PMBarry D QuartDirector
Option Exercise
13,099$14.3313,237(D)

View →

Apr 7, 2026Apr 8 8:45 PMEben TessariCHIEF STRATEGY OFFICER
Option Exercise
2,726—0(D)

View →

Apr 7, 2026Apr 8 8:44 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
2,694—0(D)

View →

Apr 7, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
9,991—0(D)

View →

Apr 6, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
7,278$10.36431,904(D)

View →

Apr 7, 2026Apr 8 8:41 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
2,497—0(D)

View →